Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEC vs TC in Advanced Ovarian Cancer
NCT00004934Phase 3Completed
- Sponsor
- Nordic Society of Gynaecological Oncology Clinical Trial Unit
- Start
- Aug 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 10
01
Overview
A Phase 3 trial of epirubicin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Nordic Society of Gynaecological Oncology Clinical Trial Unit. Started Aug 1999; status: completed.
02
Drugs
epirubicin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00004934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004934.